Table of Contents Table of Contents
Previous Page  37 / 258 Next Page
Information
Show Menu
Previous Page 37 / 258 Next Page
Page Background

148

L

in

et al

.:

J

ournal of

AOAC I

nternational

V

ol

.

100, N

o

.

1, 2017

switch valve position starts at 1

2. At 5 min, after biotin is

eluted and detected by the FD, the valve position is switched to

1

6. The flow rate then ramps to 1.5 mL/min over 1 min and

keeps until 12 min, when riboflavin is eluted and detected by the

FD. Lastly, the flow rate decreases to 0.4 mL/min over 1 min

before the valve position is switched back to 1

2. The flow rate

keeps at 0.4 mL/min until 15 min.

(

6

) 

Postcolumn pump flow rate

.—0.2 mL/min.

(b) 

Instrument configuration with an optional column

switch

.—The system should be configured as shown in

Figure 

2016.11A

.

(c) 

System pressure

.—Column pump head pressure

maximum at 600 bar or per column manufacturer’s instructions;

postcolumn reaction coil head pressure maximum at 40 bar or

per manufacturer’s instructions.

(d) 

System equilibration

.—(

1

) Turn on the FD at least 1 h

before start of analysis.

(

2

) Inject the most concentrated standard (approximately

100 ng/mL) onto the column and observe the response on

the FD. If necessary, adjust the detector gain and sensitivity

settings so that the standard curve is within the range of the

detector. After the detector settings have been determined,

inject the most concentrated standard three to four times and

note the peak areas. If the system is equilibrated, the RSD of the

standard peak areas should be <2%, and the peak areas should

not steadily increase or decrease by more than 4% from the first

injection to the third or fourth injection. If the RSD is >2%,

then locate the source of the imprecision and correct it before

beginning the sample analysis. If peak areas steadily increase

or decrease by more than 4%, the system is not equilibrated

and must be allowed to equilibrate longer. After the system

has reached equilibrium and the RSD is ≤2%, inject a set of

standards, unknown samples, and another set of standards.

Every set of unknown samples must be bracketed by standards.

(e) 

Column and system maintenance

.—The column,

postcolumn reaction coil, and system may be cleaned by using

50% methanol at an appropriate pressure, referring to

F(c)

.

G. Calculations

Quantification is obtained by using a seven-level external

standard consisting of the following concentrations: 5,

10, 20, 40, 60, 80, and 100 ng/mL. The calibration of the

standards is determined by using a polynomial regression

curve (cubic-fit).

(a) 

Calculation of stock standard concentration:

SS = S

w

× P ÷ 500 × D

1

where SS = the stock standard concentration (μg/mL); S

w

=

the standard weight (g); P = the purity of the standard (g/g);

500 = the volume of the stock solution (mL); and D

1

= the unit

conversion factor: D

1

= 1000000 μg/g.

(b) 

Calculation of intermediate standard (IS) concentration:

IS = (volume of SS used) × (SS concentration) ÷ dilution volume

(c) 

Calculation of working standards concentration level

7 (WS7):

WS7 = (volume of IS used in mL) × (concentration of IS in

µ

g/mL) ÷ (WS7 volume in mL) × 1000 ng/

µ

g

(d) 

Calculation of working standards concentration level

1–6 (WS1–6):

WS1–6 = (volume of WS7 used in mL) × (concentration of

WS7 in ng/mL) ÷ (WS1–6 volume in mL)

(e) 

Calculation of the biotin concentration in the injected

product samples (C

i

) is from its biotin peak area and the standard

curve generated from the standards.

(f) 

Calculation of original product concentration (C

p

) is,

therefore, based on the dilution scheme used for the sample:

C

p

= C

i

× D

0

÷ ss × D

1

× D

2

where C

p

= the original product concentration (μg/100g); C

i

= the

injected sample’s biotin concentration, from standard curve

(ng/mL); D

0

= the dilution of original product before filtration:

D

0

= 50 mL; ss = the sample size (g); D

1

= the unit conversion

(from per g to per 100 g sample and from ng to μg of biotin):

D

1

 = (100 g/100 g)(1 μg/1000 ng) = 1/10 g·μg/ng/100 g; and

D

2

= the conversion from sample to reconstituted finished product:

for powder, D

2

= 25 g powder ÷ (25 g powder + 200 g water) =

25 g ÷ 225 g = 1/9; for liquid (2× dilution by weight), D

2

= 2; and

for ready-to-feed (RTF; as is), D

2

= 1.

Results and Discussion

Method Validation

This method has undergone a thorough single-laboratory

validation (SLV) usingAOAC INTERNATIONAL guidelines to

probe its linearity, LOQ, specificity, accuracy, and ruggedness.

The analytical range for SPIFAN biotin-fortified matrixes

was found to be between 1.7 and 142 μg/g reconstituted final

product or RTF.

Calibration fit

.

During each analytical run, seven standards

with biotin concentrations ranging from 5 to 100 ng/mL were

injected before and after each sample set. Calibration curves were

constructed from these standards using a polynomial regression

curve (cubic-fit) and used to back-calculate the concentration of

each working standard in order to calculate calibration error at

each level. The method demonstrated good polynomial regression

(cubic) fit, over a standard range of 5–100 ng/mL biotin, with

r

2

 >0.9990. The calibration errors for the lowest two levels (near

the LOQ level) are around 25% and 10%; the calibration errors

for the remaining levels were <8% (Table 1; Figure 2).

Suitable calibration curve range

.

Due to the characteristics

of the postcolumn protein binding reaction, saturated

Table 1. Representative calibration standard data

Level

Concentration,

ng/mL

HPLC peak

area

Amount, ng/mL Error, %

1

5

0.2019

6.21

24

2

10

0.6600

9.00

10

3

20

2.2932

18.61

7

4

40

6.1743

41.03

3

5

60

9.2305

60.45

1

6

80

11.353

77.66

3

7

100

12.863

103.9

4

37